Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service? Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
Loaded Human IL-6 R alpha, Fc Tag (Cat. No. ILR-H5259) on Protein A Biosensor, can bind Human IL-6, premium grade (Cat. No. IL6-H4218) with an affinity constant of 35.9 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Sarilumab | REGN-88; SAR-153191 | Approved | Sanofi, Regeneron Pharmaceuticals Inc | Kevzara | Japan | Arthritis, Rheumatoid | Sanofi | 2017-05-22 | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Coronavirus Disease 2019 (COVID-19); Sarcoidosis; Mastocytosis, Systemic; Arthritis, Juvenile; Coronavirus Infections; Severe Acute Respiratory Syndrome; Uveitis | Details |
Satralizumab | RG-6168; SA-237 | Approved | Chugai Pharmaceutical Co Ltd | Enspryng, エンスプリング | EU | Neuromyelitis Optica | Roche Registration Gmbh | 2020-06-29 | Myasthenia Gravis; Neuromyelitis Optica; Anti-N-Methyl-D-Aspartate Receptor Encephalitis | Details |
Tocilizumab | R-1569; rhPM-1; RG-1569; RO-48775533; MRA; HPM-1; MRA-SC | Approved | Chugai Pharmaceutical Co Ltd | Actemra, RoActemra, Actemra/RoActemra, 雅美罗 | EU | Coronavirus Disease 2019 (COVID-19) | Roche Registration Gmbh | 2005-04-11 | Pulmonary Disease, Chronic Obstructive; Stroke; Graves Ophthalmopathy; Coronavirus Infections; Coronary Disease; Takayasu Arteritis; Multicentric Castleman's Disease (MCD); Severe Acute Respiratory Syndrome; Lupus Erythematosus, Systemic; systemic sclerosis-associated interstitial lung disease; Pulmonary Arterial Hypertension; Breast Neoplasms; Fever; Respiratory Distress Syndrome, Adult; Uveitis, Posterior; Inflammation; Uveitis; Lymphoma; Osteoarthritis; Rejection in heart transplantation; Carcinoma, Hepatocellular; Non-ST Elevated Myocardial Infarction; Amyotrophic Lateral Sclerosis; Behcet Syndrome; Diabetes Mellitus; Kidney Failure, Chronic; Depressive Disorder, Major; Diabetes Mellitus, Type 1; Hematologic Neoplasms; Solid tumours; Motor Neuron Disease; Craniopharyngioma; Polymyositis; HIV Infections; Uveitis, Intermediate; Myocardial Infarction; Giant Cell Arteritis; Schnitzler Syndrome; Pneumonia; Cytokine Release Syndrome; Dermatomyositis; Polyarticular Juvenile Idiopathic Arthritis; Arthritis, Rheum | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Tocilizumab biosimilar (AryoGen Pharmed) | Phase 3 Clinical | Aryogen Biopharma | Arthritis, Rheumatoid | Details | |
CMAB806 | CMAB-806 | Phase 3 Clinical | Taizhou Maibo Taike Biotechnology Co Ltd | Arthritis, Rheumatoid; Arthritis | Details |
Recombinant humanized anti-IL-6R antibody (Hisun Pharma) | HS-628 | Phase 3 Clinical | Zhejiang Hisun Pharmaceutical Co Ltd | Arthritis, Rheumatoid; Arthritis | Details |
Levilimab | BCD-089 | Phase 3 Clinical | Biocad | Coronavirus Disease 2019 (COVID-19); Arthritis, Rheumatoid | Details |
VDJ-001 | Phase 2 Clinical | Beijing Vdjbio Co Ltd | Arthritis, Rheumatoid; Multicentric Castleman's Disease (MCD) | Details | |
Olamkicept | TJ-301; FE-999301; CR-5/18; FE-301 | Phase 2 Clinical | Conaris Research Institute | Colitis, Ulcerative | Details |
Tocilizumab biosimilar (Fresenius kabi) | MSB-11456 | Phase 3 Clinical | Merck Serono | Arthritis, Rheumatoid | Details |
Atexakin alfa | SON-080; r-IL-6 | Phase 2 Clinical | Merck Serono, Weizmann Institute Of Science | Peripheral Nervous System Diseases; Diabetic Neuropathies | Details |
Tocilizumab biosimilar (Celltrion) | CT-P47; CT-P-47 | Phase 3 Clinical | Celltrion Inc | Arthritis, Rheumatoid | Details |
This web search service is supported by Google Inc.